Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Endocrinology
•
Bone and Calcium Disorders
•
Primary Care
Following abaloparatide use for osteoporosis treatment, how long do you consolidate with bisphosphonates before considering a drug holiday?
Answer from: at Community Practice
6 months
Sign In
or
Register
to read more
21202
Related Questions
How do you approach osteoporosis screening in men?
How do you screen (imaging, modality) for bone density changes following oncologic treatment in childhood cancer survivors?
How do you approach the frequency of DEXA scan monitoring for older adults on bisphosphonate therapy during the course of therapy?
For patients <65 with significant intermittent steroid exposure who otherwise do not have risk factors for osteoporosis, when, if ever, do you recommend considering DEXA screening?
When treating osteoporosis, does your duration of maintenance bisphosphonate therapy post anabolic therapy with PTH analogue change based on C-telopeptide levels?
Would you consider recommending parathyroidectomy for primary hyperparathyroidism patients with high calcium and PTH levels, even without traditional criteria, based on recent studies showing reduced anxiety and depression?
How do you decide when to treat hypocalcemia in hospitalized patients?
What is your approach to the management of chronic hyponatremia in the 131-134 range in ambulatory older adults?
Do you typically start PTH analogue therapy for osteoporosis at lower doses and gradually titrate up to improve tolerance and longer term use?
How do you approach patients with elevated total alkaline phosphatase levels, that is primarily from Intestine components rather than Bone or Hepatic components?